Duke Cancer Center /ID# 162062

Durham, North Carolina 27710-3000

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM) — Running, not enrolling